DBM

INNOVATE Corp. Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, March 4, 2024
Traction, Spectrum, FDA, DBM, Growth, Broadcasting, Federal Communications Commission, ATSC, Adjustment, Advertising, Azteca América, R2, Federal, PBS, FreeTV Australia, Patient, United, Label, Video game

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the fourth quarter and full year. Financial Summary

Key Points: 
  • “2023 was another successful year for INNOVATE, with a number of exciting developments across the three operating segments,” said Avie Glazer, Chairman of INNOVATE.
  • For the fourth quarter of 2023, Broadcasting reported revenue of $5.7 million, compared to $10.7 million in the prior year quarter.
  • For the fourth quarter of 2023, Broadcasting reported a Net Loss of $5.4 million compared to $2.8 million in the prior year quarter.
  • Revenue: For the fourth quarter of 2023, INNOVATE's consolidated revenue was $361.0 million, a decrease of 11.8%, compared to $409.3 million for the prior year quarter.

Altimetrik Unveils a Market First Digital Business Methodology

Retrieved on: 
Monday, February 19, 2024
Data Management, Apps, Applications, Technology, Software, Networks, Artificial Intelligence, Engineering, Algorithm, DBP, AI, DBA, Culture, DBM, Growth, Confusion, Consultant, Databricks, Ecosystem, SSOT, Organization, Intuition, Snowflake, McKinsey & Company, Environment, Sales

Altimetrik's unveiling of its Digital Business Methodology (DBM) leverages 10 years of experience in delivering outcomes and growth for customers.

Key Points: 
  • Altimetrik's unveiling of its Digital Business Methodology (DBM) leverages 10 years of experience in delivering outcomes and growth for customers.
  • The paradigm has shifted from digital transformation to digital business, and here businesses take the ownership to drive the outcomes by taking a holistic approach.
  • Altimetrik facilitates internalization of digital skills and culture, enabling clients to identify talent both internally and externally through the Digital Business Academy (DBA).
  • Altimetrik is a digital business pioneer and over the past decade has developed the tools and methodologies that ensures enterprises can transition to a true digital business.

Accelus Strengthens Leadership with New Board Appointments

Retrieved on: 
Monday, February 12, 2024
Cornell University, Osteon, PALM, Spine, NDO, Pathology, DBM, Growth, Subsidence, MBA, Risk, McGann, HPMS, Business administration, Villanova University, Organization, BEACH, Colgate University, Laboratory, Management

This strategic enhancement to the board is aligned with Accelus’s mission to deliver innovative spinal solutions that elevate the surgical experience and improve patient outcomes.

Key Points: 
  • This strategic enhancement to the board is aligned with Accelus’s mission to deliver innovative spinal solutions that elevate the surgical experience and improve patient outcomes.
  • His journey with Accelus includes key roles as President and Chief Commercial Officer, showcasing his leadership and strategic vision.
  • Bernie Haffey, the founder of Haffey & Co., brings to the board a proven track record in executive management and leadership.
  • “I am delighted by the addition of Kevin McGann and Bernie Haffey to the Accelus Board of Directors," said Alex Lukianov, Chairman of the Board for Accelus.

Magnesium Oxide Sales to Total US$ 8,310.7 Million by 2033 Amid Growing Usage in Refractory and Construction Industries | Future Market Insights, Inc.

Retrieved on: 
Thursday, January 11, 2024
Magnesium oxide, Associate, DBM, CCM, Construction, Growth

NEWARK, Del., Jan. 11, 2024 /PRNewswire/ -- The Global Magnesium Oxide Market value totaled US$ 4,363.2 million in 2023 and is expected to reach US$ 8,310.7 million by 2033. Over the assessment period, global magnesium oxide demand is projected to surge at a CAGR of 6.6%.

Key Points: 
  • Future Market Insights, Inc.'s latest report projects a dynamic magnesium oxide market fueled by its unparalleled adaptability and crucial role in enhancing performance across industries.
  • NEWARK, Del., Jan. 11, 2024 /PRNewswire/ -- The Global Magnesium Oxide Market value totaled US$ 4,363.2 million in 2023 and is expected to reach US$ 8,310.7 million by 2033.
  • Magnesium oxide DBM remains the widely used product in the market, holding a volume share of 56.9% in 2023.
  • Request Exclusive Sample Report: Magnesium Oxide Market Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-1622
    The global magnesium oxide market presents a dynamic landscape driven by its versatile applications across several industries and its fundamental role in enhancing the performance of diverse products and processes.

Magnesium Oxide Sales to Total US$ 8,310.7 Million by 2033 Amid Growing Usage in Refractory and Construction Industries | Future Market Insights, Inc.

Retrieved on: 
Thursday, January 11, 2024
Magnesium oxide, Associate, DBM, CCM, Construction, Growth

NEWARK, Del., Jan. 11, 2024 /PRNewswire/ -- The Global Magnesium Oxide Market value totaled US$ 4,363.2 million in 2023 and is expected to reach US$ 8,310.7 million by 2033. Over the assessment period, global magnesium oxide demand is projected to surge at a CAGR of 6.6%.

Key Points: 
  • Future Market Insights, Inc.'s latest report projects a dynamic magnesium oxide market fueled by its unparalleled adaptability and crucial role in enhancing performance across industries.
  • NEWARK, Del., Jan. 11, 2024 /PRNewswire/ -- The Global Magnesium Oxide Market value totaled US$ 4,363.2 million in 2023 and is expected to reach US$ 8,310.7 million by 2033.
  • Magnesium oxide DBM remains the widely used product in the market, holding a volume share of 56.9% in 2023.
  • Request Exclusive Sample Report: Magnesium Oxide Market Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-1622
    The global magnesium oxide market presents a dynamic landscape driven by its versatile applications across several industries and its fundamental role in enhancing the performance of diverse products and processes.

Sacrix Provides Safe Alternative to Risky Revision Spine Surgery, Publishing Groundbreaking Results in Renowned Spine Journal

Retrieved on: 
Sunday, January 7, 2024
Patient, Research, Surgeon, Literature, SIJ, Sacroiliac joint, DBM, Spine, Harvard University, Nonunion, Board certification, The, LESS, Ilium, Dentistry

BURLINGTON, Mass., Jan. 6, 2024 /PRNewswire-PRWeb/ -- The article, titled "Salvage of failed direct lateral sacroiliac joint fixation using a new percutaneous lateral-oblique transfixation technique with two variable-threaded screws," promises to redefine the realm of sacroiliac joint surgeries.

Key Points: 
  • Sacrix, a pioneer medical device company in outpatient spine surgery solutions, proudly unveils a novel Less Exposure Spine Surgery (LESS) technique that helped patients avoid major and risky revision corrective spine surgery.
  • The clinical results were summarized in a research paper authored by Board-certified Orthopedic Spine surgeons and published through a premiere peer-reviewed scientific clinical journal.
  • Dr. Richard Francis, a pioneering spine surgeon in Houston, Texas, stated, "the Sacrix technique and device is the best option for this problem."
  • The Sacrix technique offers immediate stability and documented long-term fusion, marking a significant advancement in outpatient orthopedic spine surgery.

INNOVATE Corp. Announces Third Quarter 2023 Results

Retrieved on: 
Thursday, November 9, 2023
EBITDA, PBS, HPE, Azteca América, R2, ATSC, KVIE, KERA, Broadcasting, Transdermal, FDA, Hewlett Packard Enterprise, Advertising, Adjustment, DBM, Growth, Architecture, Pharmaceutical industry, Video game, Cryptocurrency, Medical device, Azteca

WEST PALM BEACH, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the third quarter.

Key Points: 
  • DBM Global Inc. ("DBMG") reported third quarter 2023 revenue of $369.3 million, a decrease of 10.5%, compared to $412.7 million in the prior year quarter.
  • For the third quarter of 2023, Broadcasting reported revenue of $5.4 million, compared to $9.1 million in the prior year quarter.
  • For the third quarter of 2023, Broadcasting reported Net Loss of $6.5 million compared to $1.4 million in the prior year quarter.
  • Revenue: For the third quarter of 2023, INNOVATE's consolidated revenue was $375.3 million, a decrease of 11.3%, compared to $423.0 million for the prior year quarter.

Altimetrik Launches Digital Business Academy to Address Digital Talent Needs

Retrieved on: 
Monday, October 30, 2023
Technology, Software, Digital, Learning, DBA, Pocs, Growth, Aircraft, Certification, Student, DBM, Creative industries, Management

Altimetrik , a pure-play digital business company, has launched the Digital Business Academy (DBA), a comprehensive program designed to enable companies to mature their digital skills and cultures with the help of its Digital Business Methodology (DBM) .

Key Points: 
  • Altimetrik , a pure-play digital business company, has launched the Digital Business Academy (DBA), a comprehensive program designed to enable companies to mature their digital skills and cultures with the help of its Digital Business Methodology (DBM) .
  • The DBA, tailored for all organizational levels from the C-suite to engineering professionals, offers crucial talent enablement, guaranteeing efficient digital adoption across all business functions.
  • This offering aims to internalize the development of digital practitioners at scale, bridging talent gaps so companies can achieve sustainable growth paths.
  • It extends beyond technical skill development; it's a proven pathway to cultivate a DBM and capabilities that enable companies to internalize a digital business culture to achieve growth.

Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures

Retrieved on: 
Thursday, October 12, 2023
Medical Devices, FDA, Health, Other Health, Physical Therapy, Biotechnology, Surgeon, Multimedia, Growth, DBM, Federal Food, Drug, and Cosmetic Act, Spine, Osteon, Ceramic

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove™, an advanced bioactive synthetic graft.

Key Points: 
  • Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove™, an advanced bioactive synthetic graft.
  • Available in both a putty and strip configuration, OsteoCove was carefully formulated to provide superior bone-forming capabilities with best-in-class handling characteristics for a wide range of spine and orthopedic procedural applications.
  • This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20231012672479/en/
    Image of OsteoCove putty and strip, an advanced bioactive synthetic graft formulated to provide superior bone-forming capabilities with best-in-class handling characteristics for a wide range of spine and orthopedic procedural applications.

Kleiner Device Labs Awarded Patent for KG®2 Surge® flow-thru interbody system

Retrieved on: 
Monday, October 9, 2023
Patent, Surgeon, Burkholder, MD, I Am the Moon, DBM, Titanium, KG2, Cultured pearl

INCLINE VILLAGE, Nev., Oct. 9, 2023 /PRNewswire/ -- Kleiner Device Labs today announced that it was recently awarded a U.S. patent for its new KG®2 Surge® flow-thru interbody system.

Key Points: 
  • INCLINE VILLAGE, Nev., Oct. 9, 2023 /PRNewswire/ -- Kleiner Device Labs today announced that it was recently awarded a U.S. patent for its new KG®2 Surge® flow-thru interbody system.
  • This adds to the company's growing global portfolio of 35 issued patents and other intellectual property for spinal surgical technology developed by the company.
  • "The technology that we developed with the KG2 Surge system simplifies the post-insertion delivery of a wide range of graft materials through the interbody and into the surrounding disc space," added CTO Alan Burkholder.
  • The new KG2 Surge flow-thru interbody system was developed with the objectives of maximizing bone graft delivery to the prepared intervertebral disc space, and streamlining implant placement, positioning, and integration in the graft matrix.